| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Options Exercise | $2,023,399 | +22,321 | +584% | $90.65 | 26,145 | 04 Mar 2024 | Direct | |
| transaction | MEDP | Common Stock | Sale | $8,996,033 | -22,321 | -85% | $403.03 | 3,824 | 04 Mar 2024 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Options Exercise | $1,602,601 | +17,679 | +462% | $90.65 | 21,503 | 05 Mar 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -22,321 | -56% | $0.000000 | 17,679 | 04 Mar 2024 | Common Stock | 22,321 | $90.65 | Direct | F3 |
| transaction | MEDP | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -17,679 | -100% | $0.000000* | 0 | 05 Mar 2024 | Common Stock | 17,679 | $90.65 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The transactions reported on this line of this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $401.60 to $404.525. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
| F3 | The option vested in full on August 5, 2019. |